Waverton Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $270M | Buy |
665,000
+70,271
| +12% | +$28.5M | 3.71% | 10 |
|
|
2025
Q1 | $296M | Buy |
594,729
+52,324
| +10% | +$26M | 4.58% | 5 |
|
|
2024
Q4 | $282M | Buy |
542,405
+62,189
| +13% | +$32.4M | 4.49% | 5 |
|
|
2024
Q3 | $297M | Buy |
480,216
+49,100
| +11% | +$30.4M | 4.88% | 3 |
|
|
2024
Q2 | $238M | Buy |
431,116
+65,120
| +18% | +$36M | 4.49% | 5 |
|
|
2024
Q1 | $213M | Buy |
365,996
+89,688
| +32% | +$52.1M | 4.42% | 6 |
|
|
2023
Q4 | $147M | Buy |
276,308
+153,344
| +125% | +$81.5M | 3.56% | 16 |
|
|
2023
Q3 | $62.3M | Sell |
122,964
-3,699
| -3% | -$1.87M | 1.8% | 21 |
|
|
2023
Q2 | $66M | Buy |
126,663
+44,130
| +53% | +$23M | 1.88% | 21 |
|
|
2023
Q1 | $47.6M | Buy |
82,533
+1,042
| +1% | +$601K | 1.47% | 21 |
|
|
2022
Q4 | $44.9M | Buy |
81,491
+1,702
| +2% | +$937K | 1.65% | 18 |
|
|
2022
Q3 | $40.5M | Buy |
79,789
+11,819
| +17% | +$5.99M | 1.66% | 18 |
|
|
2022
Q2 | $36.9M | Buy |
67,970
+8,350
| +14% | +$4.54M | 1.44% | 21 |
|
|
2022
Q1 | $35.2M | Buy |
59,620
+6,927
| +13% | +$4.09M | 1.19% | 23 |
|
|
2021
Q4 | $35.2M | Buy |
52,693
+38,393
| +268% | +$25.6M | 1.12% | 23 |
|
|
2021
Q3 | $8.17M | Hold |
14,300
| – | – | 0.32% | 33 |
|
|
2021
Q2 | $7.21M | Sell |
14,300
-1,400
| -9% | -$706K | 0.28% | 34 |
|
|
2021
Q1 | $7.17M | Hold |
15,700
| – | – | 0.31% | 31 |
|
|
2020
Q4 | $7.31M | Buy |
15,700
+3,700
| +31% | +$1.72M | 0.34% | 34 |
|
|
2020
Q3 | $5.3M | Hold |
12,000
| – | – | 0.26% | 33 |
|
|
2020
Q2 | $4.35M | Sell |
12,000
-2,001
| -14% | -$725K | 0.24% | 33 |
|
|
2020
Q1 | $3.97M | Buy |
+14,001
| New | +$3.97M | 0.26% | 32 |
|